Clinical Trials Directory

Trials / Completed

CompletedNCT03618498

Internal Limiting Membrane Flaps for Coexistent Macular Hole and Retinal Detachment

Internal Limiting Membrane Flaps for Coexistent Macular Hole and Retinal Detachment in Eyes of Proliferative Diabetic Retinopathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Changhua Christian Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Purpose: To evaluate the logical surgical approaches in closing macular holes in eyes of proliferative diabetic retinopathy with retinal detachment

Detailed description

High MH closure rate can be achieved. Other than high myopia, MH with RD may appear in several conditions, such as severe vitreomacular traction, proliferative diabetic retinopathy (PDR).clinical charts were reviewed of patients of proliferative diabetic retinopathy suffering from MH with RD who were treated with vitrectomy combined with inverted epiretinal ILM flap,inverted ILM flaps insertion techniques, or free ILM flaps.Standard 3-port 23 or 25 gauged pars plana vitrectomy was performed. After core vitrectomy, anterior-posterior oriented tractions as well as all fibrovascular tissues were removed as thoroughly as possible.The patients were kept in a facedown position overnight and were allowed to take any positions except supine for approximately one week.Various surgical approaches utilizing in managing macular hole may effectively closing macular holes and reattach retina.

Conditions

Interventions

TypeNameDescription
PROCEDUREILM flaps insertion techniques or free ILM flaps.The ILM flap anchoring on the hole edge was inverted and covered the hole.Otherwise, temporal side ILM flap was used. However, if the risk of ILM flipping back was judged to be high, ILM insertion instead of ILM hole coverage was adopted.If the size of the ILM flaps was judged inadequate, the double ILM insertion technique was used, done by adding a piece of previously obtained free ILM flap on top of the inverted ILM tissue until they were securely in place.

Timeline

Start date
2018-03-07
Primary completion
2018-05-31
Completion
2018-07-15
First posted
2018-08-07
Last updated
2018-08-08

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03618498. Inclusion in this directory is not an endorsement.